2 assets in Mouth Disorder

Therapeutic assets addressing Mouth Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Pembrolizumab Mouth Disorder	VLP Therapeutics	P1	CC (43)
Vrp-Encapsulated Sarna Encoding Il-12 Mouth Disorder	VLP Therapeutics	P1	CC (43)